#Japan #Tokyo #scheme verge #AI Medical Checker #Hakuhodo Medical

Introduction

In recent years, the medical industry has seen a growing demand for efficiency and accuracy in medical reviews. To address this need, Scheme Verge Co., Ltd., a Tokyo-based AI startup, has developed the AI Medical Checker in collaboration with Hakuhodo Medical. This innovative tool significantly streamlines the medical review process, ensuring compliance with stringent regulatory standards.

Background on Medical Review Challenges

The marketing of prescription drugs requires meticulous medical reviews to adhere to various regulations. Traditionally, these reviews have been handled manually, which can be time-consuming and labor-intensive. As the complexity of regulations, including the Blue Book guidelines set by the Japan Pharmaceutical Manufacturers Association, continues to grow, the burden on medical writers has intensified. In fact, approximately 40% of a medical writer's time is consumed by these review tasks, impacting their ability to focus on more creative and specialized writing responsibilities.

Moreover, the intricate interdependencies of these regulations necessitate a high level of inference abilities, which adds another layer of complexity to the review process. This challenge extends beyond Hakuhodo Medical, posing a significant issue for the entire medical sector, prompting the need for innovative solutions.

Features of the AI Medical Checker

The AI Medical Checker is designed to enhance efficiency and improve accuracy in medical reviews. Here are some of its standout features:

1. Comprehensive Checks Based on the Blue Book: The AI Medical Checker is programmed to cover essential aspects that might be overlooked during manual checks by ensuring that all relevant points are accurately addressed.

2. Substantial Reduction in Workload: By leveraging AI to quickly analyze vast amounts of documents and information, the Medical Checker cuts down the time previously spent on manual reviews, allowing medical writers to allocate their time more effectively.

3. High Reliability Utilizing Medical Writers’ Tacit Knowledge: The system incorporates the tacit knowledge of experienced medical writers into its patented technology, ensuring high precision in the detection of compliance issues and enhancing the credibility of the review process.

4. Structured Analysis of Specialized Documents: The AI is capable of automatically analyzing specialized documents like the Comprehensive Product Information Overview, enabling effective checks that align with the structure of headings and major/minor topics.

Through these features, the AI Medical Checker not only drastically reduces the workload of reviewers but also enhances the overall efficiency of related tasks. By integrating Hakuhodo Medical's extensive expertise and know-how, the solution is poised to elevate quality standards across the board.

Upcoming Presentation at Pharma DX Expo Tokyo

Excited about the innovation, Scheme Verge and Hakuhodo Medical will showcase the AI Medical Checker at the upcoming 1st Pharma DX Expo Tokyo from July 9 to 11, 2025, at Tokyo Big Sight. Interested individuals are encouraged to visit their booth in the South 3-4 Hall, with the booth number S23-10, for demonstrations and further insights into the software. Additionally, they will hold product and technical seminars during the expo:

• - July 9: 11:40 - 12:10
• - July 10: 11:40 - 12:10

Given the limited space, pre-registration is recommended via this link.

Technical Background and Academic Presentation

The development process and technical background of the AI Medical Checker have been documented in a paper to be presented at the 39th National Conference of the Japanese Society for Artificial Intelligence on May 27, 2025. The paper titled “Creating Value and Empowerment through AI in the Production of Promotional Tools for Prescription Drugs” is authored by notable figures in the field and is expected to enrich the conference discussions.

Future Outlook for Hakuhodo Medical

Hakuhodo Medical aims to expand the AI Medical Checker’s functionalities further, with plans for advanced detection capabilities and document generation features on the horizon. The company continues to lead the way in developing innovative solutions that leverage AI and digital technology to support pharmaceutical marketing and promotional activities, contributing to groundbreaking advancements in Japan’s healthcare landscape.

About Scheme Verge

Scheme Verge, a Tokyo University-origin AI startup, focuses on promoting digital transformation (DX) across various industries. The company aims to reinvent urban management through data integration and has cultivated significant expertise in AI solutions for the medical sector. Their mission is to facilitate the development of AI and automation solutions, including the AI Medical Checker, to enhance the efficiency of business processes in collaboration with partners across multiple fields.

For further inquiries regarding this innovative development, interested parties may contact Hakuhodo Medical at hakuhodo.medical@hakuhodo-medical.co.jp. More details about Hakuhodo Medical's offerings can be found on their website.